Melbourne Renal Research Group

Reservoir, Victoria 3073

1 studies enrolling now · 9 studies all time

What they study most

ADPKD, Alport Syndrome, Autosomal Dominant Polycystic Kidney, Cardiovascular Risk, Chronic Kidney Disease, Chronic Kidney Diseases, Diabetic Nephropathies, Hyperkalemia, IgA Nephropathy, Immunoglobulin A Nephropathy, Inflammation, Non-diabetic Chronic Kidney Disease

Studies at this site

• A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• Atrasentan in Patients With IgA Nephropathy — Running, not enrolling
• A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease — Completed
• A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON — Stopped early
• An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) — Stopped early
• An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants — Completed
• A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy — Completed
• Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia — Completed